| Product Code: ETC9461838 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sri Lanka Antimicrobial Resistance Market Overview |
3.1 Sri Lanka Country Macro Economic Indicators |
3.2 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Sri Lanka Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Sri Lanka Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Sri Lanka Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Sri Lanka Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Sri Lanka Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Sri Lanka Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Sri Lanka Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Sri Lanka |
4.2.2 Growing awareness about antimicrobial resistance among healthcare professionals and the general population |
4.2.3 Government initiatives to combat antimicrobial resistance through regulatory measures and public health campaigns |
4.3 Market Restraints |
4.3.1 Lack of proper antibiotic stewardship programs in healthcare facilities |
4.3.2 Limited access to advanced diagnostic tools for determining appropriate antibiotic usage |
4.3.3 High cost of antimicrobial drugs in Sri Lanka |
5 Sri Lanka Antimicrobial Resistance Market Trends |
6 Sri Lanka Antimicrobial Resistance Market, By Types |
6.1 Sri Lanka Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sri Lanka Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sri Lanka Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Sri Lanka Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Sri Lanka Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Sri Lanka Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Sri Lanka Antimicrobial Resistance Market Export to Major Countries |
7.2 Sri Lanka Antimicrobial Resistance Market Imports from Major Countries |
8 Sri Lanka Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage increase in the adoption of guidelines for antimicrobial stewardship programs in healthcare facilities |
8.2 Number of educational workshops and training sessions conducted on antimicrobial resistance for healthcare professionals |
8.3 Percentage improvement in the appropriate use of antibiotics based on diagnostic testing |
8.4 Number of public health campaigns and initiatives launched by the government to raise awareness about antimicrobial resistance |
8.5 Rate of decrease in the sales volume of broad-spectrum antibiotics in Sri Lanka |
9 Sri Lanka Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Sri Lanka Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Sri Lanka Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Sri Lanka Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Sri Lanka Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Sri Lanka Antimicrobial Resistance Market - Competitive Landscape |
10.1 Sri Lanka Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Sri Lanka Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here